Impact Investing
The Spanish Health Sector Reduced Greenhouse Emissions by 1.2% in 2022
The estimates of the emissions into the atmosphere account are made from the National Inventories of Emissions into the Atmosphere, prepared by the Ministry for the Ecological Transition and the Demographic Challenge. Regarding the emission of greenhouse gases from activities related to the manufacturing of pharmaceutical products, the total value in 2022 was 880,000 tons.
The health sector in Spain slightly improved its commitment to the environment. Healthcare activities emitted 1.11 million tons of greenhouse gases in 2022, 1.2 % less than the value reached in 2021, when the maximum in the last decade was reached, with 1.12 million tons.
Read more about the greenhouse emissions of the Spanish health sector and find the latest business news of the day with our companion app Born2Invest.
Despite the decrease, the health sector’s greenhouse emission is still higher than pre-pandemic levels, according to the latest data from the National Institute of Statistics (INE)
Not counting the decrease recorded during the year of the pandemic, the amount of gases has not stopped increasing since 2015. The largest increase in the historical series took place in 2019, with an increase of 15.6%. That was the year in which one million tons of polluting gases were exceeded again, a figure that had not been reached since 2011. In fact, the historical maximum was recorded in 2010, when the amount exceeded 1.16 million tons.
Regarding the emission of greenhouse gases from activities related to the manufacturing of pharmaceutical products, the total value in 2022 was 880,000 tons, its lowest value in the last six years. In this case, the quantity has not exceeded one million tons since 2013; From then on, there were four years of declines close to 10%.
Regarding the total activities of the Spanish economy, the country emitted 304.4 million tons of greenhouse gases in 2022, 3.1% more than in 2021. By branches of activities and households, the manufacturing industry accounted for 24.4% of the total, a decrease of 6.2% compared to last year, while homes generated 22.7% of total emissions, 1.0%. 2% more than in 2021.
The health sector ranked 25th in 2022
In the 2022 sector ranking, healthcare activities ranked 25th; For its part, the manufacturing of pharmaceutical products was ranked 27th. The least polluting branches were the activities of households as employers of domestic staff or as producers of goods and services for own use, and the repair of computers, personal effects, and household items.
Environmental Accounting aims to integrate environmental information coherently into the central system of National Accounts. It includes a set of satellite accounts, transmitted annually, prepared from accounting formats applicable to different sectoral and territorial areas, with a strong presence of physical data. Shows the interactions between the economy, households, and environmental factors.
The air emissions account presents data on polluting emissions into the atmosphere, in a manner compatible with the System of National Accounts, recording the emitting agents disaggregated by branches of economic activity and households as final consumers.
The estimates of the emissions into the atmosphere account are made from the National Inventories of Emissions into the Atmosphere, prepared by the Ministry for the Ecological Transition and the Demographic Challenge.
__
(Featured image by Marcin Jozwiak via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Markets2 weeks ago
Markets Surge on Trump Victory—But Can Overvaluation and Recession Risks Stall the Rally?
-
Biotech4 days ago
Sanofi Injects 40 Million Euros to Strengthen Its Production in France
-
Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
-
Crypto2 days ago
Bitcoin ETF Options Debut in the U.S.: Is a New All-Time High on the Horizon?